NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM3602034 Query DataSets for GSM3602034
Status Public on Apr 01, 2019
Title H1299 Omomyc biological replica 2
Sample type RNA
 
Source name NCI-H1299
Organism Homo sapiens
Characteristics cell line: NCI-H1299
tumor type: lung carcinoma
treatment: Omomyc
Treatment protocol Cells were plated and after overnight incubation, vehicle or 12.8 µM Omomyc treatement were added
Growth protocol Cells were grown at 37ºC, 5% CO2 in RPMI1640 supplemented with glutamine and 10% FBS
Extracted molecule total RNA
Extraction protocol Total RNA were extracted using TRIzol following manufacturer's procedures. Total RNA was quantified using a NanoDrop Spectrophotometer ND-1000 (NanoDrop Technologies, Inc.) and its integrity was assessed using a 2100 Bioanalyzer (Agilent Technologies).
Label Biotin
Label protocol Labeling of samples was carried out according to the manufacturer’s standard protocol
 
Hybridization protocol Total RNA was linearly amplified using WT Plus (Affymetrix). The resulting ssDNA was used to hybridize Affimetrix microarrays. Hybridization data was acquired using the Affimetrix GeneChip/GeneTitan platforms. Transcriptomes were determined on a genome wide Clariom S Human HT (Affimetrix).
Scan protocol Arrays were scanned on a Affymetrix GeneTitan instrument (ThermoFisher Scientific-Affymetrix) according to the manufacturer’s protocol.
Data processing Affymetrix CEL files were normalized by RMA preprocessing methodology and analyzed using Partek Genomic Suite followed by GSEA 3.0 software from Broad Institute.
 
Submission date Feb 12, 2019
Last update date Apr 02, 2019
Contact name Marie-Eve Beaulieu
E-mail(s) [email protected]
Organization name Peptomyc
Street address Natzaret 115-117
City Barcelona
State/province Catalunya
ZIP/Postal code 08035
Country Spain
 
Platform ID GPL24324
Series (2)
GSE126453 Effect of Omomyc treatment on human lung adenocarcinoma cell lines
GSE126455 Effect of Omomyc treatment on lung adenocarcinoma of KRasLSL-G12D/+ transgenic mouse and human lung adenocarcinoma cell lines

Data table header descriptions
ID_REF
VALUE Quantification

Data table
ID_REF VALUE
AFFX-BkGr-GC03_st 6.7983
AFFX-BkGr-GC04_st 6.2712
AFFX-BkGr-GC05_st 6.32422
AFFX-BkGr-GC06_st 6.18824
AFFX-BkGr-GC07_st 5.8215
AFFX-BkGr-GC08_st 3.48702
AFFX-BkGr-GC09_st 3.0167
AFFX-BkGr-GC10_st 2.8268
AFFX-BkGr-GC11_st 2.6658
AFFX-BkGr-GC12_st 2.81071
AFFX-BkGr-GC13_st 2.50658
AFFX-BkGr-GC14_st 2.53124
AFFX-BkGr-GC15_st 2.39995
AFFX-BkGr-GC16_st 2.48066
AFFX-BkGr-GC17_st 2.57991
AFFX-BkGr-GC18_st 2.83639
AFFX-BkGr-GC19_st 5.74468
AFFX-BkGr-GC20_st 5.5634
AFFX-BkGr-GC21_st 5.86323
AFFX-BkGr-GC22_st 5.80208

Total number of rows: 24351

Table truncated, full table size 635 Kbytes.




Supplementary file Size Download File type/resource
GSM3602034_UAT-2017-F-0097.CEL.gz 1.0 Mb (ftp)(http) CEL
GSM3602034_UAT-2017-F-0097.sst-rma-gene-full.chp.gz 175.1 Kb (ftp)(http) CHP
Processed data included within Sample table
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap